(The Center Square) – Belgian pharmaceutical company UCB Inc. is opening a biologics manufacturing facility in Gwinnett County, according to Georgia Gov. Brian Kemp.
The facility will be located at the Rowen Foundation’s 2,000-acre science and learning campus in Gwinnett County and will create 330 new jobs.
UCB’s North American headquarters are in Smyrna and the company employs 400 people in the Peach State, the governor and company officials said in a release.
“UCB’s announcement is also a significant milestone for our life sciences industry, representing one of the largest investments in state history and establishing both the Rowen facility and Georgia as a true hub of innovation in this field,” Kemp said.
The governor said the talks with UCB took place during a trip to Belgium.
“This decision reflects our confidence in UCB’s long-term growth and our deep-rooted commitment to the United States,” said Jean-Christophe Tellier, UCB’s chief executive officer. “This project is expected to generate approximately $5 billion in total economic impact, reflecting the broader value it will create for the region and its communities.”
The new biologics manufacturing facility will anchor the Rowen campus, a partnership between the Rowen Foundation and Gwinnett County, according to its website.
“We are thrilled that UCB has chosen Gwinnett County to advance its global operations and pioneering innovations,” said Chairwoman Nicole Love Hendrickson, Gwinnett County Board of Commissioners. “An investment of this magnitude was exactly what we envisioned when we committed to establishing Rowen as a hub for collaboration and discovery.
